A Study of MK-6194 (PT101) in Participants with Active Ulcerative Colitis (UC) (MK-6194-002)

Trial Identifier: 6194-002
Sponsor: MSD
Start Date: October 2021
Primary Completion Date: January 2024
Study Completion Date: July 2024
Condition: Ulcerative Colitis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary - English
Results Plain Language Summary - EMEA Ukrainian
Results Plain Language Summary - EMEA Georgian

Trial Locations

Country Location
Georgia, Tbilisi Tbilisi, Georgia, 0112
Germany, Berlin Berlin, Germany, 10117
Hungary, Budapest Budapest, Hungary, 1007
Moldova, Republic of, Chisinau Chisinau, Moldova, Republic of, 2025
Poland, Malopolskie Nowy Targ, Malopolskie, Poland, 34-400
Poland, Mazowieckie Warszawa, Mazowieckie, Poland, 00-728
Ukraine, Kyivska oblast Kyiv, Kyivska oblast, Ukraine, 01135
United Kingdom, Barnsley Barnsley, United Kingdom, S75 3DL
United Kingdom, Knowsley Prescot, Knowsley, United Kingdom, L34 1BH
United Kingdom, Lancashire Blackpool, Lancashire, United Kingdom, FY2 0JH
United Kingdom, Leeds Leeds, United Kingdom, LS10 1DU
United Kingdom, Manchester Manchester, United Kingdom, M13 9NQ
United States, CA Rialto, CA, United States, 92377
United States, FL Kissimmee, FL, United States, 34741
United States, NC Raleigh, NC, United States, 27607
United States, TX San Antonio, TX, United States, 78229